European Journal of Chemistry 2016, 7(3), 357-362 | doi: https://doi.org/10.5155/eurjchem.7.3.357-362.1470 | Get rights and content

Issue cover





  Open Access OPEN ACCESS | Open Access PEER-REVIEWED | RESEARCH ARTICLE | DOWNLOAD PDF | VIEW FULL-TEXT PDF | TOTAL VIEWS

Enantiomeric separation and quantitation of warfarin and its metabolites in human plasma by LC-MS/MS


Ahmed Abd-Alazim Mostafa (1,*)

(1) Pharmaceutical Chemistry Department, Faculty of Pharmacy, Helwan University, Egypt, Ein Helwan, 11795, Cairo,
(*) Corresponding Author

Received: 18 Jun 2016 | Accepted: 14 Jul 2016 | Published: 30 Sep 2016 | Issue Date: September 2016

Abstract


The enantiomeric separation of warfarin (WAR) enantiomers and its hydroxy metabolites positional isomers is described in this work. The utilization of chiral chromatography coupled to Tandem mass spectrometry helps to achieve that. The developed method was able to separate R,S-warfarin and enantiomers of 4,7,10-hydroxy warfarin in human plasma. Plasma samples were processed with simple protein precipitation with acetonitrile. The chromatographic separation was done on chiral Astec Chirobiotic V column with gradient flow of 0.1% aqueous formic acid and 0.1% formic in acetonitrile:water (95:5, v:v). The mass spectroscopic detection was done via negative mode multiple reaction monitoring (MRM) on a triple quadrupole mass spectrometer coupled with positive electrospray ionization (ESI). Linearity of the method was valid over a concentration range of 125.00-0.13 µg/mL for racemic WAR, 47.000-0.088 µg/mL for racemic 4’-OH-WAR, 56.00-0.18 µg/mL for racemic 7-OH-WAR and 56.00-0.02 µg/mL for racemic 10-OH-WAR. The LLOQs were found to be 0.13 µg/mL for racemic WAR, 0.088 µg/mL for racemic 4’-OH-WAR, 0.18 µg/mL for racemic 7-OH-WAR and 0.02 µg/mL for racemic 10-OH-WAR. The method was validated for matrix effect, intra- and inter-day precision, freeze/thaw and storage stability. Accuracy and precision were within acceptable range (<15%). Enantiomeric forms of WAR and its metabolites were separated by the chiral column. Standards for R- and S-WAR identified peak 2 as S-WAR while metabolite peaks could not be definitively identified. Peak 2 for 7-OH-WAR gave higher blood levels, while the opposite applied to 10-OH-WAR.


Announcements


Our editors have decided to support scientists to publish their manuscripts in European Journal of Chemistry without any financial constraints.

1- The article processing fee will not be charged from the articles containing the single-crystal structure characterization or a DFT study between September 15, 2023 and October 31, 2023 (Voucher code: FALL2023).

2. A 50% discount will be applied to the article processing fee for submissions made between September 15, 2023 and October 31, 2023 by authors who have at least one publication in the European Journal of Chemistry (Voucher code: AUTHOR-3-2023).

3. Young writers will not be charged for the article processing fee between September 15, 2023 and October 31, 2023 (Voucher code: YOUNG2023).


Editor-in-Chief
European Journal of Chemistry

Keywords


Warfarin; LC-MS/MS; Metabolites; Enantiomers; Chiral chromatography; Enantiomeric separation

Full Text:

PDF
PDF    Open Access

DOI: 10.5155/eurjchem.7.3.357-362.1470

Links for Article


| | | | | | |

| | | | | | |

| | | |

Related Articles




Article Metrics

icon graph This Abstract was viewed 1479 times | icon graph PDF Article downloaded 499 times


Citations

/


[1]. Jun Haginaka, Arisa Kubo, Tetsutaro Kimachi, Yusuke Kobayashi
Retention and molecular-recognition mechanisms of molecularly imprinted polymers for warfarin derivatives and their application for the determination of warfarin in human serum
Talanta  232, 122419, 2021
DOI: 10.1016/j.talanta.2021.122419
/


References


[1]. Bern, M. M.; Lokich, J. J.; Wallach, S. R.; Bothe, J. A.; Benotti, P. N.; Arkin, C. F.; Greco, F. A.; Huberman, M.; Moore, C. Ann. Intern. Med. 1990, 112, 423-428.
http://dx.doi.org/10.7326/0003-4819-76-3-112-6-423

[2]. Ridker, P. M.; Goldhaber, S. Z.; Danielson, E.; Rosenberg, Y.; Eby, C. S.; Deitcher, S. R.; Cushman, M.; Moll, S.; Kessler, C. M.; Elliott, C. G.; Paulson, R.; Wong, T.; Bauer, K. A.; Schwartz, B. A.; Miletich, J. P.; Bounameaux, H.; Glynn, R. J. N. Engl. J. Med. 2003, 348, 1425-1434.
http://dx.doi.org/10.1056/NEJMoa035029

[3]. Radwan, M. A.; Bawazeer, G. A.; Aloudah, N. M.; AlQuadeib, B. T.; Aboul-Enein, H. Y. J. Chromatogr. B Biomed. App. 2012, 26, 6-11.

[4]. Kaminsky, L. S.; Zhang, Z. Y. Pharmacol. Ther. 1997, 73, 67-74.
http://dx.doi.org/10.1016/S0163-7258(96)00140-4

[5]. Rettie, A. E.; Korzekwa, K. R.; Kunze, K. L.; Lawrence, R. F.; Eddy, A. C.; Aoyama, T.; Gelboin, H. V.; Gonzalez, F. J.; Trager, W. F. Chem. Res. Toxicol. 1992, 5, 54-59.
http://dx.doi.org/10.1021/tx00025a009

[6]. Scordo, M. G.; Pengo, V.; Spina, E.; Dahl, M. L.; Gusella, M.; Padrini, R. Clin. Pharmacol. Ther. 2002, 72, 702-710.
http://dx.doi.org/10.1067/mcp.2002.129321

[7]. Loebstein, R.; Yonath, H.; Peleg, D.; Almog, S.; Rotenberg, M.; Lubetsky, A.; Roitelman, J.; Harats, D.; Halkin, H.; Ezra, D. Clin. Pharmacol. Ther. 2001, 70, 159-164.
http://dx.doi.org/10.1067/mcp.2001.117444

[8]. Giuseppe, L.; Elena, R.; Antonio Maria, L.; Valerio De, S. Curr. Med. Chem. Cardiovasc. Hematol. Agents. 2004, 2, 311-326.
http://dx.doi.org/10.2174/1568016043356183

[9]. Miller, G. P.; Jones, D. R.; Sullivan, S. Z.; Mazur, A.; Owen, S. N.; Mitchell, N. C.; Radominska-Pandya, A.; Moran, J. H. Chem. Res. Toxico. 2009, 22, 1239-1245.
http://dx.doi.org/10.1021/tx900031z

[10]. Redman, A. R.; Zheng, J.; Shamsi, S. A.; Huo, J.; Kelly, E. J.; Ho, R. J. Y.; Ritchie, D. M.; Yuen, Y. H. Clin. Appl. Thromb. Hemost. 2008, 14, 29-37.
http://dx.doi.org/10.1177/1076029607304403

[11]. Piatkov, I.; Rochester, C.; Jones, T.; Boyages, S. Toxins (Basel) 2010, 2, 2584-2592.
http://dx.doi.org/10.3390/toxins2112584

[12]. Hirsh, J. Am. J. Cardiol. 1995, 75, 39B-42B.

[13]. Gübitz, G. Chromatographia 1990, 30, 555-564.
http://dx.doi.org/10.1007/BF02269804

[14]. Sekhon, B. S. Int. J. Pharmtech. Res. 2010, 2, 1584-1159.

[15]. Zuo, Z.; Wo, S. K.; Lo, C. M. Y.; Zhou, L.; Cheng, G.; You, J. H. S. J. Pharm. Biomed. Anal. 2010, 52, 305-310.
http://dx.doi.org/10.1016/j.jpba.2010.01.005

[16]. Locatelli, I.; Kmetec, V.; Mrhar, A.; Grabnar, I. J. Chromatogr. B Biomed. Sci. Appl. 2005, 818, 191-198.

[17]. Ring, P. R.; Bostick, J. M. J. Pharm. Biomed. Anal. 2000, 22, 573-581.
http://dx.doi.org/10.1016/S0731-7085(00)00232-6

[18]. Malakova, J.; Pavek, P.; Svecova, L.; Jokesova, I.; Zivny, P.; Palicka, V. J. Chromatogr. B Biomed. Sci. Appl. 2009, 877, 3226-3230.

[19]. Wang, X.; Hou, J.; Jann, M.; Hon, Y. Y.; Shamsi, S. A. J. Chromatogr. A 2013, 1271, 207-216.
http://dx.doi.org/10.1016/j.chroma.2012.11.046

[20]. Heneedak, H. M.; Salama, I.; Mostafa, S.; El-Kady, E.; El-Sadek, M. Biomed. Chrom. 2015, 29, 998-1007.
http://dx.doi.org/10.1002/bmc.3384

[21]. Mostafa, A.; Medley, G.; Roberts, D. M.; Mohamed, M. S.; Elshanawani, A. A.; Roberts, M. S.; Liu, X. J. Chromatogr. B Biomed. App. 2011, 879, 2234-2238.

[22]. Kim, S. Y.; Kang, J. Y.; Hartman, J. H.; Park, S. H.; Jones, D. R.; Yun, C. H.; Boysen, G.; Miller, G. P. Drug Metab. Lett. 2012, 6, 157-164.
http://dx.doi.org/10.2174/1872312811206030002


How to cite


Mostafa, A. Eur. J. Chem. 2016, 7(3), 357-362. doi:10.5155/eurjchem.7.3.357-362.1470
Mostafa, A. Enantiomeric separation and quantitation of warfarin and its metabolites in human plasma by LC-MS/MS. Eur. J. Chem. 2016, 7(3), 357-362. doi:10.5155/eurjchem.7.3.357-362.1470
Mostafa, A. (2016). Enantiomeric separation and quantitation of warfarin and its metabolites in human plasma by LC-MS/MS. European Journal of Chemistry, 7(3), 357-362. doi:10.5155/eurjchem.7.3.357-362.1470
Mostafa, Ahmed. "Enantiomeric separation and quantitation of warfarin and its metabolites in human plasma by LC-MS/MS." European Journal of Chemistry [Online], 7.3 (2016): 357-362. Web. 23 Sep. 2023
Mostafa, Ahmed. "Enantiomeric separation and quantitation of warfarin and its metabolites in human plasma by LC-MS/MS" European Journal of Chemistry [Online], Volume 7 Number 3 (30 September 2016)

The other citation formats (EndNote | Reference Manager | ProCite | BibTeX | RefWorks) for this article can be found online at: How to cite item



DOI Link: https://doi.org/10.5155/eurjchem.7.3.357-362.1470


CrossRef | Scilit | GrowKudos | Researchgate | Publons | ScienceGate | Scite | Lens | OUCI

WorldCat Paperbuzz | LibKey Citeas | Dimensions | Semanticscholar | Plumx | Kopernio | Zotero | Mendeley

ZoteroSave to Zotero MendeleySave to Mendeley



European Journal of Chemistry 2016, 7(3), 357-362 | doi: https://doi.org/10.5155/eurjchem.7.3.357-362.1470 | Get rights and content

Refbacks

  • There are currently no refbacks.




Copyright (c)





© Copyright 2010 - 2023  Atlanta Publishing House LLC All Right Reserved.

The opinions expressed in all articles published in European Journal of Chemistry are those of the specific author(s), and do not necessarily reflect the views of Atlanta Publishing House LLC, or European Journal of Chemistry, or any of its employees.

Copyright 2010-2023 Atlanta Publishing House LLC. All rights reserved. This site is owned and operated by Atlanta Publishing House LLC whose registered office is 2850 Smith Ridge Trce Peachtree Cor GA 30071-2636, USA. Registered in USA.